Fluocinonide
Who holds supplier records for Fluocinonide? 4 organisations hold a current record for Fluocinonide: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Netherlands (1), Italy (1), Israel (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fluocinonide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fluocinonide
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fluocinonide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsActive DMF 21261, 4591 · latest filing Jan 2008
- Farmabios S.p.A.Italy Company GMP cert on recordActive DMF 21430 · latest filing Mar 2008
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 14151 · latest filing May 1999
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaActive DMF 35221 · latest filing Nov 2020
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Fluocinonide are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- NOBEL CHEMICALS AB DIV FINE CHEMICALS INCInactive DMF 7503 · filed May 1988
- QUATRUMInactive DMF 7432 · filed Apr 1988
- FARMABOISInactive DMF 7391 · filed Mar 1988
- CESQUISA SAInactive DMF 7384 · filed Feb 1988
- Brazil · Inactive DMF 3112 · filed Jan 1978
Overview
Fluocinonide is a potent synthetic corticosteroid used to treat a variety of inflammatory skin disorders. It is effective in reducing symptoms like swelling, itching, and redness.
Chemical identity
- IUPAC name
- [2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate
- Canonical SMILES
- CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C
- InChIKey
- WJOHZNCJWYWUJD-IUGZLZTKSA-N
- Synonyms
- Lidex API, fluocinolide, fluocinolone acetonide impurity m, lidex, nsc-101791, vanos
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fluocinonide?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Fluocinonide: TAPI NL BV (Netherlands), Farmabios S.p.A. (Italy), Taro Pharmaceutical Industries Ltd. (Israel) and TIANJIN TIANYAO PHARMACEUTICALS CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fluocinonide Drug Master Files are active?
TAPI NL BV (DMF 21261, 4591), Farmabios S.p.A. (DMF 21430), Taro Pharmaceutical Industries Ltd. (DMF 14151) and TIANJIN TIANYAO PHARMACEUTICALS CO LTD (DMF 35221). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fluocinonide records mean?
5 organisations have only inactive Type II DMFs for Fluocinonide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Fluocinonide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fluocinonide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.